$LIFE

SC US (TTGP), LTD. sold $4.7M of LIFE (indirect holdings)

SC US (TTGP), LTD. sold 142,616 indirectly-held shares of Ethos Technologies Inc. (LIFE) at an average of $33.05 ($32.52–$34.05, $4.71M total) across 8 trades over 2026-08-19 to 2026-08-20. Filed jointly with SC U.S. Venture XV Management, L.P. (10% owner), SEQUOIA CAPITAL U.S. VENTURE FUND XV, L.P. (10% owner), SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XV (Q), L.P. (10% owner), SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XV, L.P. (10% owner), SEQUOIA CAPITAL U.S. VENTURE XV PRINCIPALS FUND, L.P. (10% owner), SC U.S. Growth VIII Management, L.P. (10% owner) and Sequoia Capital U.S. Growth Fund VIII, L.P. (10% owner).

Original reporting
SEC EDGAR · SC US (TTGP), LTD., SC U.S. Venture XV Management, L.P., SEQUOIA CAPITAL U.S. VENTURE FUND XV, L.P., SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XV (Q), L.P., SEQUOIA CAPITAL U.S. VENTURE PARTNERS FUND XV, L.P., SEQUOIA CAPITAL U.S. VENTURE XV PRINCIPALS FUND, L.P., SC U.S. Growth VIII Management, L.P., Sequoia Capital U.S. Growth Fund VIII, L.P.
Published Aug 21, 2026, 8:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LIFE
Bearish
medium confidence
Mentioned
$LIFE
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFEBearishLow
01

Why it matters

The complete exit of a 10% owner may be interpreted as a negative signal, but the size is modest relative to market cap.

02

Market read

Primary insider sale disclosure with modest dollar amount; limited trading relevance.

03

What to watch

Potential upcoming financing or strategic transaction not yet disclosed.

Relevance 6/10Novelty 7/10Timing: filed today

Background

The filing is a routine SEC Form 4 disclosure of an insider transaction.

Company-level read

Ticker impact

$LIFEBearishMedium confidence
Context

SEC Form 4 shows a 10% owner sold all 142,616 shares for $4.7M, reducing ownership to zero.

Expected impact

Potential short-term downside as market absorbs the sell signal.

Evidence & confidence

Insider sales are often viewed negatively, especially a full divestiture by a large shareholder.

Market effects

Minimal impact on the broader biotech sector; the sale is company‑specific.

No regional effect beyond the issuer's share price.

Limited to investors tracking insider activity.

Counterpoint

The sale could be a portfolio rebalancing unrelated to fundamentals, so the stock may be undervalued.

Key entities

  • Ethos Technologies Inc.

    Issuer of the Form 4 filing.

  • SC US (TTGP), LTD.

    10% owner who sold the shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LIFEMed

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

Ethos Technologies (LIFE) reported Q2 revenue growth of 113% to $189.6M, with new policies up 133%. Gross profit margin was 98%, but net income rose only 5% to $19.5M. The company authorized a $100M stock buyback. Q3 revenue guidance is $160M-$164M, and full-year guidance is $727M-$731M. Margins compressed, with GAAP net loss of $146.9M for H1 2026 due to stock-based compensation.

$LIFEMedAI 9/10

Ethos (LIFE) Q2 2026 Earnings Call Transcript

Ethos Technologies (LIFE) reported Q2 2026 revenue of $189.6 million, up 113% Y/Y, with direct revenue $116.5 million (+131%) and third-party revenue $73.1 million (+90%). Adjusted EBITDA was $35.2 million (19% margin). Net income was $19.5 million. Full-year 2026 guidance: revenue $727-$731 million and adjusted EBITDA $119-$123 million. Up to $100 million Class A repurchase authorized.

$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

$LIFEHigh

Ethos Technologies Inc. (LIFE): Results of Operations and Financial Condition

Ethos Technologies Inc. (LIFE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ethos Reports Second Quarter Fiscal Year 2026 Financial Results • Q2 Revenue grew 113% year-over-year to $190 million • Q2 Direct Channel Revenue grew 131% year-over-year to $116 million • Q2 Third-Party Revenue grew 90% year-over-year to $73 million • Board of Direc